Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Research and Markets: ImmunoGen, Inc. - Product Pipeline Review - 2012

Research and Markets
Posted on: 08 Oct 12

Research and Markets (http://www.researchandmarkets.com/research/dk9m4f/immunogen_inc) has announced the addition of Global Markets Direct's new company profile "ImmunoGen, Inc. - Product Pipeline Review - 2012" to their offering.

This report provides data on the ImmunoGen, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope:

- Brief ImmunoGen, Inc. overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of ImmunoGen, Inc. human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of ImmunoGen, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the ImmunoGen, Inc.'s pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to Buy:

- Evaluate ImmunoGen, Inc.'s strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of ImmunoGen, Inc. in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the ImmunoGen, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with ImmunoGen, Inc..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of ImmunoGen, Inc. and identify potential opportunities in those areas.

For more information visit http://www.researchandmarkets.com/research/dk9m4f/immunogen_inc

Source: Global Markets Direct

Business Wire
http://www.businesswire.com/

Last updated on: 08/10/2012

Advertising